GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celestra Inc (XKRX:352770) » Definitions » Net Income (Continuing Operations)

Celestra (XKRX:352770) Net Income (Continuing Operations) : ₩-54,917 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Celestra Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Celestra's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ₩-10,133 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-54,917 Mil.


Celestra Net Income (Continuing Operations) Historical Data

The historical data trend for Celestra's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celestra Net Income (Continuing Operations) Chart

Celestra Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income (Continuing Operations)
Get a 7-Day Free Trial -13,146.60 15,852.88 -10,234.42 -42,399.16 -47,055.13

Celestra Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,270.58 -5,140.49 -6,881.54 -32,762.52 -10,132.72

Celestra Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-54,917 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celestra  (XKRX:352770) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Celestra Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Celestra's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Celestra Business Description

Industry
Traded in Other Exchanges
N/A
Address
Building 110, UNIST, 50, Suite 301-3, UNIST-gil, Eonyang-eup, Ulju-gun, Ulsan, KOR, 44919
Celestra Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology. It offers a genome-based, early cancer diagnostic service through technology for multi-omics analysis and simultaneous detection of CTC and cfDNA in the blood based.

Celestra Headlines

No Headlines